Literature DB >> 639196

Urinary kallikrein in rats bred for their susceptibility and resistance to the hypertensive effect of salt. A new radioimmunoassay for its direct determination.

O A Carretero, V M Amin, T Ocholik, A G Scicli, J Koch.   

Abstract

Urinary kallikrein was measured in rats bred to be susceptible (S) or resistant (R) to the hypertensive effect of salt. To determine kallikrein, three different methods were used: (1) a new direct radioimmunoassay (RIA) for the enzymic protein: (2) a method based on the capability of kallikrein, when incubated with kininogen, to generate kinins which were then measured by RIA (kininogenase activity); and (3) a method based on the capability of kallikrein to break the ester bond of p-tosyl-L-arginine methyl ester (HCl (TAMe). A significant correlation ( r = 0.90) was found between the direct RIA and the kininogenase method. It was found that urinary kallikrein was significantly decreased in the S as compared to the R rats by the use of these three methods. Urinary kallikrein in the S rats was much lower when measured by the kininogenase method than by direct RIA or esterolytic assay. This difference could be due to excretion of pre-kallikrein and/or kallikrein bound to an inhibitor (inactive kallikrein). It is suggested that the decrease of urinary kallikrein excretion (active and inactive) in the S rats could be a consequence of a genetic defect that may affect the development of hypertension perhaps through the alteration of sodium and water excretion by the kidney.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639196     DOI: 10.1161/01.res.42.5.727

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Specific identification of tissue kallikrein in exocrine tissues and in cell-free translation products with monoclonal antibodies.

Authors:  C M Woodley; J Chao; H S Margolius; L Chao
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

2.  Kinin-forming system in the genesis of hypertension.

Authors:  J N Sharma
Journal:  Agents Actions       Date:  1984-02

3.  Structural studies of human urinary kallikrein (urokallikrein).

Authors:  O K ole-MoiYoi; J Spragg; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

Review 4.  The renal kallikrein-kinin system in human and in experimental hypertension.

Authors:  O A Carretero; A G Scicli
Journal:  Klin Wochenschr       Date:  1978

5.  Activation of membrane-bound kallikrein and renin in the kidney.

Authors:  K Nishimura; F Alhenc-Gelas; A White; E G Erdös
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

Review 6.  [Renal kallikrein-kinin system and control of blood pressure (author's transl)].

Authors:  A Distler; H P Wolff
Journal:  Klin Wochenschr       Date:  1979-10-01

Review 7.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 8.  Human tissue kallikrein in the treatment of acute ischemic stroke.

Authors:  Michelle Alexander-Curtis; Rick Pauls; Julie Chao; John J Volpi; Philip M Bath; Todd A Verdoorn
Journal:  Ther Adv Neurol Disord       Date:  2019-01-20       Impact factor: 6.570

Review 9.  Role of Kinins in Hypertension and Heart Failure.

Authors:  Suhail Hamid; Imane A Rhaleb; Kamal M Kassem; Nour-Eddine Rhaleb
Journal:  Pharmaceuticals (Basel)       Date:  2020-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.